Predicting drug response from genomic mutations with a 6.36B parameter transformer
We are building the future of cancer treatment. Quark uses a custom cancer genomics transformer to create personalized therapy recommendations that maximize efficacy while minimizing side effects.
| Metric | Value |
|---|---|
| 🧠 Model parameters | 6.36B |
| 🎯 Cancer type accuracy | 100% |
| 💊 Drug response accuracy | 96.15% |
| 📚 CIViC clinical entries | 1,227 |
| Technology | Description |
|---|---|
| Digital Patient Twins | Genomic, proteomic and imaging integration for treatment modeling |
| 3D Drug Simulation | Molecular-level chemotherapy simulation before administration |
| Medical Imaging | BiomedCLIP-powered pathology classification and tissue analysis |
| CRISPR Protocol Generator | AI-designed therapeutic gene editing protocols |
| CAR-T Cell Designer | Multi-antigen targeting with AI-optimized immune engineering |
| FDA Compliance | Regulatory tracking for clinical trial readiness |
- 🚀 Platform: quarkclinical.com/login
- 📊 Investor deck: quarkclinical.com/pitch
- 🌐 Website: quarkclinical.com
- 💼 LinkedIn: Danjal Mutic
- 📧 Email: danjalmutic@quarkclinical.com
🏥 Using AI to save lives ✨
Sweden 🇸🇪